Arcus Biosciences. Every tracked FinTwit mention of $RCUS, newest first. 19 mentions since the first on Jun 13, 2025. See the price chart.
February 2026 · 1 mention
Feb 28
Jacob Plieth — $MRK Welireg could be about to expand its reach at last. #GU26 data via @ApexOnco with relevance to $RCUS -> https://t.co/k59284INdK↗
December 2025 · 3 mentions
Dec 12
Jacob Plieth — Say hello to $AZN, last man standing in #tigit, and holder of an unconfortable similarity to $RCUS $GILD. Via @ApexOnco -> https://t.co/mqqRC9NaGZ↗
Dec 12
Jacob Plieth — So where does this the #tigit Fc debate?
Fc-active: $GSK $ITOS fail, $MRK fail, $RHHBY fail
Fc-silent: $RCUS $GILD fail
Fc-reduced: $AZN $CGEN ?↗
Dec 12
Jacob Plieth — After $RHHBY #Tigit failed in Skyscraper-14 $RCYS $GILD terminate Star-221 for futility. Evidently someone was surprsed as $RCUS is -12% PM↗
November 2025 · 1 mention
Nov 6
Jacob Plieth — Quick reminder: I make that 6,536 patients on late-stage rilvegostomig trials $AZN $GILD $RCUS #tigit https://t.co/Qy6CxQTCIc↗
October 2025 · 10 mentions
Oct 22
Jacob Plieth — Who won #ESMO25 and who lost? Via @ApexOnco
https://t.co/EWzHIIH1Ck
$IOBT $CELC $RCUS $CGEM $IDYA $NUVL $AGEN $GILD $DSNKY $INCY $CATX $LPTX $OLMA $SMMT $AVBP $GMAB $EXEL $CGEN $Z…↗
Oct 20
Jacob Plieth — A #tigit postmortem from $RHHBY at #ESMO25. Tic toc $RCUS.
Via @ApexOnco -> https://t.co/UOtLHj3eqY↗
Oct 20
Jacob Plieth — Good morning biotwitter! If you're catching up with #ESMO25 here's what we've published over the weekend https://t.co/lzhy6k4Raz
Stocks to watch this morning: $GMAB $CELC $IOBT $MR…↗
Oct 19
Jacob Plieth — Almost the last #tigit standing: $RCUS $GILD domvanalimab flies the flag at #ESMO25. Via @ApexOnco -> https://t.co/XYS3AY42W3
September 2025 · 1 mention
Sep 25
Jacob Plieth — Kudos to $RHHBY for not trying to bury its Tigit failures. 4 pivotal trials will feature at #ESMO25, incl 2 late-breakers & Imbrave-152.
Via @ApexOnco -> https://t.co/8rgBs3…↗
July 2025 · 2 mentions
Jul 24
Jacob Plieth — @avidresearch ...and is still being wasted! $AZN $RCUS $GILD↗
Jul 24
Jacob Plieth — 5,000 patients later $RHHBY finally dumps its #tigit (Sky-14 is quietly said to have failed). Via @ApexOnco -> https://t.co/nAdoMmG6tI $RCUS $GILD $AZN https://t.co/ufrJGMzbh1↗
June 2025 · 1 mention
Jun 13
Jacob Plieth — What's this, me being positive about $RCUS??
Peak-1 is posted on ct-gov, and that's a good opportunity to back into casdatifan combo data form #ASCO25
Via @ApexOnco https://t.co/A…↗
Jacob Plieth — Yelena Janjigian: "dom is an Fc-silent MAb so most of the infusion-related reactions are likely due to the PD-1."
Yes, I had to relisten to that bit to check that she really did s…↗
Oct 18
Jacob Plieth — And here's one of the last two men standing in #tigit, $RCUS $GILD domvanalimab: first disclosure of OS curves from Edge-Gastric, via Yelena Janjigian #ESMO25 https://t.co/KKB3YDuj…↗
Oct 18
Jacob Plieth — Meanwhile, here's Skyscraper-03, stage III NSCLC. #tigit combo is no better than Imfinzi, but adds tox. No attempt by Rafal Dziaduszko to gloss over how bad these data are #ESMO25…↗
Oct 6
Jacob Plieth — Casdatifan ORR up, tox up. Still just about better than $MRK Welireg on a X-trial basis. $RCUS +9% https://t.co/Xz8Yto8Ny3↗
Oct 6
Jacob Plieth — Median PFS not reached is a positive sign given median follow-up is 12.4 months, but too soon to say if casdatifan 100mg has hit Evercore's 17-18mth "good" or 20mth "excellent" sce…↗
Oct 6
Jacob Plieth — $RCUS expanding into immunology & inflammation https://t.co/DBbg1CpxQW↗